XSHE300405
Market cap197mUSD
Dec 24, Last price
5.13CNY
1D
0.39%
1Q
30.87%
Jan 2017
-57.92%
IPO
-25.15%
Name
Liaoning Kelong Fine Chemical Inc
Chart & Performance
Profile
Liaoning Kelong Fine Chemical,Inc. manufactures and sells fine chemicals worldwide. The company offers polycarboxylate concrete admixture products, including polycarboxylate-based superplasticizers, slump retaining agents, and slump and water retaining admixtures, as well as polycarboxylate-based superplasticizers in powder forms; and polycarboxylate macro monomer products comprising polyether monomers, polyoxyethylene monoallyl ethers, and methoxy polyethylene glycol methacrylate. It also provides glycol ether products consisting of 2-phenoxyethanol and 1-phenoxy-2-propanol; and auxiliaries of textiles, such as hydrogen peroxide stabilizers, hydrophilic modifiers for amino silicon oils, and synthetic fiber hydrophilic finishing agents. In addition, the company offers polyethylene glycol monomethyl ether, hydrophilic polyester copolymer, castor oil ethoxylate, phosphate ester, polyoxyalkylene glycol/polyether, hydrophilic amino silicone oil, polyethylene glycol, sorbitan oleate and laurate, sorbitan stearate and trioleate, fatty alcohol and nonyl phenol ethoxylate, isotridecanol ethoxylate, and polyglycol glycidic ether condensation products; polyoxyethylene sorbitan monooleate, monolaurate, monostearate, and trioleate; and polyethylene glycol monooleate, monolaurate, and monostearate. Its polycarboxylate superplasticizers, cutting fluids, paint additives, and concrete admixtures are used in various areas, such as daily chemicals, pharmacy, textile printing, etc. The company was founded in 1988 and is based in Liaoyang, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 558,445 -28.52% | 781,226 -28.29% | 1,089,410 17.23% | |||||||
Cost of revenue | 573,124 | 798,575 | 984,851 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (14,679) | (17,349) | 104,558 | |||||||
NOPBT Margin | 9.60% | |||||||||
Operating Taxes | 6,131 | |||||||||
Tax Rate | ||||||||||
NOPAT | (20,810) | (17,349) | 104,558 | |||||||
Net income | (100,230) | 11,924 | ||||||||
Dividends | (27,268) | (6,674) | ||||||||
Dividend yield | 1.47% | 0.43% | ||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 563,521 | 555,046 | 523,415 | |||||||
Long-term debt | 1,376 | 236 | ||||||||
Deferred revenue | 20,805 | 22,863 | 24,922 | |||||||
Other long-term liabilities | 1 | 1 | 1,891 | |||||||
Net debt | 388,376 | 342,137 | 328,830 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 10,480 | 17,984 | ||||||||
CAPEX | (25,952) | |||||||||
Cash from investing activities | (38,517) | 33,429 | ||||||||
Cash from financing activities | 45,113 | 42,955 | 8,408 | |||||||
FCF | 8,303 | 112,653 | 88,895 | |||||||
Balance | ||||||||||
Cash | 162,145 | 212,273 | 193,763 | |||||||
Long term investments | 13,000 | 2,012 | 1,059 | |||||||
Excess cash | 147,223 | 175,224 | 140,351 | |||||||
Stockholders' equity | 148,242 | 340,430 | 363,696 | |||||||
Invested Capital | 957,280 | 1,051,416 | 1,192,994 | |||||||
ROIC | 9.11% | |||||||||
ROCE | 7.82% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 288,019 | 289,210 | 289,210 | |||||||
Price | 6.46 20.75% | 5.35 -29.03% | 7.54 13.69% | |||||||
Market cap | 1,860,600 20.25% | 1,547,273 -29.03% | 2,180,198 13.69% | |||||||
EV | 2,261,170 | 1,901,678 | 2,532,845 | |||||||
EBITDA | 28,857 | 30,792 | 149,699 | |||||||
EV/EBITDA | 78.36 | 61.76 | 16.92 | |||||||
Interest | 27,288 | 27,724 | 31,822 | |||||||
Interest/NOPBT | 30.43% |